Stay Curious. Stay Connected.
MailNewsletters♡Donate Now
Sign up
*Password must be at least 8 characters and contain one uppercase letter, one lowercase letter, one number and one symbol.
Already have an account?
By submitting, you consent that you are at least 18 years of age and to receive information about MPR's or APMG entities' programs and offerings. The personally identifying information you provide will not be sold, shared, or used for purposes other than to communicate with you about MPR, APMG entities, and its sponsors. You may opt-out at any time clicking the unsubscribe link at the bottom of any email communication. View our Privacy Policy.
Sign in to your profile
Forgot Password?
New to MPR News?
Welcome back
to news
for you
Reset Password

Enter the username on file and we'll send you a code to reset your password.

Still require assistance or not sure what your User Name is?
Welcome back
to news
for you
Email Verification

A verification code has been emailed to

Still awaiting the code?

Health

Health
UK investigates possible allergic reactions to COVID-19 shot

UK investigates possible allergic reactions to COVID-19 shot

U.K. regulators said Wednesday that people who have a "significant history'' of allergic reactions shouldn't receive the new Pfizer-BioNTech vaccine while they investigate two adverse reactions that occurred on the first day of the country's mass vaccination program.
by The Associated Press

Go Deeper.

Create an account or log in to save stories.

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

Dec. 9 update on COVID-19 in MN: 82 more deaths; cases, hospitalizations ebb

Dec. 9 update on COVID-19 in MN: 82 more deaths; cases, hospitalizations ebb

The newest death toll extends an already difficult December, although other pandemic measures improved. Still, Minnesota may soon hit 400,000 cases after passing 300,000 cases less than two weeks ago, the state’s health commissioner says.
by MPR News Staff

Go Deeper.

Create an account or log in to save stories.

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

What you need to know: Minnesota's vaccine distribution plan

What you need to know: Minnesota's vaccine distribution plan

Health care workers and residents of long-term care facilities will be the first to receive the vaccine. Here’s what you need to know about the vaccine and Minnesota’s distribution plan.
by Dan Kraker

Go Deeper.

Create an account or log in to save stories.

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

Can Minnesota close gaps and lead in early childhood development?

Can Minnesota close gaps and lead in early childhood development?

As part of the annual conference for Little Moments Count — an initiative focused on early childhood development — advocates highlighted how racial disparities and COVID-19 are affecting families with young children and what Minnesota needs to do to close the gaps.
by Angela Davis

Go Deeper.

Create an account or log in to save stories.

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

State by state, wildly different responses to the same viral outbreak

State by state, wildly different responses to the same viral outbreak

The United States confirmed its first case of COVID-19 in late January and is now approaching 300,000 deaths from the disease. In the intervening months, the response to the pandemic — from restrictions to testing access — has largely been left up to the states. What do current caseloads and hospitalizations across the country tell us about mitigation efforts?
by Kerri Miller and Marcheta Fornoff

Go Deeper.

Create an account or log in to save stories.

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

Feds passed up chance to lock in more Pfizer vaccine doses

Feds passed up chance to lock in more Pfizer vaccine doses

The Trump administration's coronavirus vaccine effort is coming under new scrutiny after failing to lock in a chance to buy millions of additional doses of Pfizer's vaccine, which has shown to be highly effective against COVID-19. That decision could delay the delivery of a second batch of doses until manufacturer Pfizer fulfills other international contracts.
by The Associated Press

Go Deeper.

Create an account or log in to save stories.

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

U.S. regulators post positive review of Pfizer vaccine data

U.S. regulators post positive review of Pfizer vaccine data

Documents released by U.S. regulators Tuesday confirmed that Pfizer and BioNTech's COVID-19 vaccine was strongly protective against COVID-19 — offering the world's first detailed look at the evidence behind the shots.
by The Associated Press

Go Deeper.

Create an account or log in to save stories.

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

‘Route out’ of pandemic: UK gives 1st COVID-19 vaccine doses

‘Route out’ of pandemic: UK gives 1st COVID-19 vaccine doses

A retired British shop clerk received the first shot in the country’s COVID-19 vaccination program Tuesday, signaling the start of a global immunization effort intended to offer a route out of a pandemic that has killed 1.5 million.
by The Associated Press

Go Deeper.

Create an account or log in to save stories.

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.